- Home
- MAS vs NBIX Comparison
MAS vs NBIX Comparison
Compare MAS & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAS | NBIX |
|---|---|---|
| Founded | 1929 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.1B | 13.9B |
| IPO Year | 1994 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MAS | NBIX |
|---|---|---|
| Price | $65.39 | $129.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 22 |
| Target Price | $75.86 | ★ $175.23 |
| AVG Volume (30 Days) | ★ 2.8M | 1.2M |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.87% | N/A |
| EPS Growth | 2.66 | ★ 41.95 |
| EPS | 3.86 | ★ 4.67 |
| Revenue | ★ $7,562,000,000.00 | $161,626,000.00 |
| Revenue This Year | $2.80 | $22.85 |
| Revenue Next Year | $3.38 | $9.99 |
| P/E Ratio | ★ $17.72 | $28.56 |
| Revenue Growth | N/A | ★ 977.51 |
| 52 Week Low | $56.55 | $84.23 |
| 52 Week High | $79.19 | $160.18 |
Technical Indicators
Market Signals| Indicator | MAS | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 33.23 | 43.80 |
| Support Level | $64.17 | $129.17 |
| Resistance Level | $66.21 | $137.37 |
| Average True Range (ATR) | 2.09 | 3.31 |
| MACD | -1.22 | 0.43 |
| Stochastic Oscillator | 3.34 | 55.58 |
Price Performance
Historical ComparisonAbout MAS Masco Corporation
Masco manufactures a variety of home improvement and building products. The company's $5 billion plumbing segment, led by the Delta and Hansgrohe brands, sells faucets, showerheads, and other related plumbing fixtures and components. The roughly $3 billion decorative architectural segment primarily sells paints and other coatings under the Behr and Kilz brands, but it also sells builder hardware products.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.